PARAPHARMACIE BASUNGA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PARAPHARMACIE BASUNGA
Largest movements
- Cash -€3,532
down €3,532 (-28.3%), from €12,501 to €8,970
mainly Receivables within one year (-€2,278) and Net result for the year (-€1,188)
- Receivables within one year +€2,278
up €2,278 (+188%), from €1,210 to €3,487
- Profit (loss) carried forward -€1,188
down €1,188 (-125%), from -€948 to -€2,136
- Gross operating margin +€1,370
up €1,370 (+56.9%), from -€2,409 to -€1,039
- Financial charges -€49
down €49 (-24.6%), from €198 to €149
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €13,711 | €12,457 | -€1,254 | -9.1% |
| Current assets | 29/58 | €13,711 | €12,457 | -€1,254 | -9.1% |
| Amounts receivable within one year | 40/41 | €1,210 | €3,487 | +€2,278 | +188% |
| Other amounts receivable | 41 | €1,210 | €3,487 | +€2,278 | +188% |
| Cash at bank and in hand | 54/58 | €12,501 | €8,970 | -€3,532 | -28.3% |
| Total equity and liabilities | 10/49 | €13,711 | €12,457 | -€1,254 | -9.1% |
| Equity | 10/15 | €13,312 | €12,124 | -€1,188 | -8.9% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€948 | -€2,136 | -€1,188 | -125% |
| Amounts payable | 17/49 | €399 | €333 | -€66 | -16.6% |
| Amounts payable within one year | 42/48 | €399 | €333 | -€66 | -16.6% |
| Trade debts | 44 | €399 | €333 | -€66 | -16.6% |
| Suppliers | 440/4 | €399 | €333 | -€66 | -16.6% |
| Gross operating margin | 9900 | -€2,409 | -€1,039 | +€1,370 | +56.9% |
| Operating profit (loss) | 9901 | -€2,409 | -€1,039 | +€1,370 | +56.9% |
| Financial charges | 65/66B | €198 | €149 | -€49 | -24.6% |
| Recurring financial charges | 65 | €198 | €149 | -€49 | -24.6% |
| Profit (loss) for the period before taxes | 9903 | -€2,607 | -€1,188 | +€1,419 | +54.4% |
| Profit (loss) for the period | 9904 | -€2,607 | -€1,188 | +€1,419 | +54.4% |
| Profit (loss) for the period to be appropriated | 9905 | -€2,607 | -€1,188 | +€1,419 | +54.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.